People 18 years or older with autism spectrum disorder (ASD) and who have a significant mood disorder or other behaviors that interfere with function and quality of life are needed to take part in a Johns Hopkins research study.
The study will last 14 weeks total: During six weeks, participants will receive a pill containing cannabidiol (CBD); during one to two weeks, participants will receive no drug/placebo; and during six weeks, participants will receive the placebo, an inactive pill.
As part of the study, participants will have regular visits and be asked questions about anxiety, challenging behaviors, daily functioning, cognition, and physical symptoms, on standard assessments that are not usually asked in routine clinical care.
Call 443-863-8648 for details.
